ATPC vs. AIRS, VMD, TOI, XGN, DCGO, CORBF, EUDA, KDLY, QIPT, and NAKA
Should you be buying Agape ATP stock or one of its competitors? The main competitors of Agape ATP include AirSculpt Technologies (AIRS), Viemed Healthcare (VMD), Oncology Institute (TOI), Exagen (XGN), DocGo (DCGO), Global Cord Blood (CORBF), EUDA Health (EUDA), Kindly MD (KDLY), Quipt Home Medical (QIPT), and KindlyMD (NAKA). These companies are all part of the "healthcare" industry.
Agape ATP vs. Its Competitors
Agape ATP (NASDAQ:ATPC) and AirSculpt Technologies (NASDAQ:AIRS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, community ranking, media sentiment, analyst recommendations and dividends.
AirSculpt Technologies has a consensus target price of $3.75, suggesting a potential downside of 27.04%. Given AirSculpt Technologies' stronger consensus rating and higher possible upside, analysts plainly believe AirSculpt Technologies is more favorable than Agape ATP.
Agape ATP has higher earnings, but lower revenue than AirSculpt Technologies. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Agape ATP, indicating that it is currently the more affordable of the two stocks.
AirSculpt Technologies received 11 more outperform votes than Agape ATP when rated by MarketBeat users. Likewise, 35.48% of users gave AirSculpt Technologies an outperform vote while only 0.00% of users gave Agape ATP an outperform vote.
0.0% of Agape ATP shares are held by institutional investors. Comparatively, 91.5% of AirSculpt Technologies shares are held by institutional investors. 9.7% of Agape ATP shares are held by company insiders. Comparatively, 76.6% of AirSculpt Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
AirSculpt Technologies has a net margin of -9.95% compared to Agape ATP's net margin of -191.34%. AirSculpt Technologies' return on equity of -15.01% beat Agape ATP's return on equity.
Agape ATP has a beta of -0.82, meaning that its share price is 182% less volatile than the S&P 500. Comparatively, AirSculpt Technologies has a beta of 2.46, meaning that its share price is 146% more volatile than the S&P 500.
In the previous week, Agape ATP's average media sentiment score of 0.00 beat AirSculpt Technologies' score of -0.15 indicating that Agape ATP is being referred to more favorably in the media.
Summary
AirSculpt Technologies beats Agape ATP on 12 of the 16 factors compared between the two stocks.
Get Agape ATP News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATPC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ATPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Agape ATP Competitors List
Related Companies and Tools
This page (NASDAQ:ATPC) was last updated on 6/25/2025 by MarketBeat.com Staff
Buy ATPC Stock Free ATPC Stock Alerts